Gene expression profile identifies distinct molecular subtypes and potential therapeutic genes in Merkel cell carcinoma

• Main Authors: Umair Ali Khan Saddozai, Fengling Wang, Yu Cheng, Zhang Lu, Muhammad Usman Akbar, Wan Zhu, Yongqiang Li, Xinying Ji, Xiangqian Guo
• Format: Article
• Language: English
• Published: Elsevier 2020-11-01
• Series: Translational Oncology
• Subjects: Merkel cell carcinoma; Molecular subtype; Gene expression; Subtype specific treatment
• Online Access: http://www.sciencedirect.com/science/article/pii/S1936523320303089

Merkel cell carcinoma (MCC) is a rare primary cutaneous neoplasm of neuroendocrine carcinoma of the skin. About 80% of the MCC occurs due to Merkel cell polyomavirus (MCPyV) and 20% of the tumors usually occur due to severe UV exposure which is a more aggressive type of MCC. It tends to have an increased incidence rate among elderly and immunosuppressed individuals. On therapeutic level, sub-classification of MCC through molecular subtyping has emerged as a promising technique for MCC prognosis. In current study, two consistent distinct molecular subtypes of MCCs were identified using gene expression profiling data. Subtypes I MCCs were associated with spliceosome, DNA replication and cellular pathways. On the other hand, genes overexpressed in subtype II were found active in TNF signalling pathway and MAPK signalling pathway. We proposed different therapeutic targets based on subtype specificity, such as PTCH1, CDKN2A, AURKA in case of subtype I and MCL1, FGFR2 for subtype II. Such findings may provide fruitful knowledge to understand the intrinsic subtypes of MCCs and the pathways involved in distinct subtype oncogenesis, and will further advance the knowledge in developing a specific therapeutic strategy for these MCC subtypes.